|
|
Article: Cancer Vaccine Pioneer At NYU To Review Personalized Cancer Vaccines, Pioneering Biotherapies Are At Advanced Trials Stage.
- Article from:
- Business Wire
- Article date:
- January 25, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
NEW YORK--(BUSINESS WIRE)--Jan. 25, 2001
Dr. Larry W. Kwak, M.D., Ph.D., Senior Investigator at the National Institutes of Health, will present published findings related to work on personalized cancer vaccine technologies, at 1 p.m. on Jan. 26, 2001, at The New York University Medical Center (NYU). Specifically, Dr. Kwak will discuss pioneering advances in the field of tumor-specific personalized cancer vaccines, to treat a variety of lethal cancers.
As one example, on Sept. 27, 1999, the National Cancer Institute (NCI) announced that, for the first time ever, results of a Phase II cancer vaccine study ...